Batista's partial left ventricular resection in end-stage congestive heart failure

被引:0
|
作者
Beyersdorf, F [1 ]
vandeLoo, A [1 ]
机构
[1] UNIV FREIBURG KLINIKUM,HERZ KREISLAUF ZENTRUM,ABT KARDIOL ANGIOL,D-79106 FREIBURG,GERMANY
关键词
partial ventricular resection; terminal heart failure; organ preserving operations;
D O I
10.1007/BF03044255
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Congestive heart failure is a clinical condition with a high mortality. Medical therapy has improved the clinical course of these patients considerably in recent years. Numerous surgical interventions such as high risk coronary bypass surgery resection of left ventricular aneurysms, heart valve replacement and cardiac transplantation became accepted therapeutical options. More recently transmyocardial laser revascularization, implantation of mechanical assist devices, implantable cardioverters/defibrillators and dynamic cardiomyoplasty were introduced into clinical practice and are still under evaluation. For most patients suffering from congestive heart failure cardiac transplantation is the only therapeutical option. However, age of the patients, decreasing number of donors, mortality on the waiting list, high morbidity under immunosuppressive therapy and graft vasculopathy characterize the problems of this therapeutical strategy. The brasilian cardiac surgeon Randas Batista therefore has introduced a new organ preserving surgical technique. First reports on ''partial left ventricular resection'' for patients with end-stage cardiac failure and dilated ventricles are promising. The possible importance of this new surgical technique implies that precise clinical and scientific evaluation are imperatively needed. In this review we present the surgical procedure, published data on clinical outcome and hemodynamic changes and possible indications for this new technique. The few data which have been published so far might indicate that there is an acceptable perioperative mortality associated with a symptomatic improvement. However, intermediate and long-term follow-up data are not available, and refinements in the surgical technique are necessary.
引用
收藏
页码:272 / 276
页数:5
相关论文
共 50 条
  • [31] Partial left ventriculectomy to treat end-stage heart disease
    Batista, RJV
    Verde, J
    Nery, P
    Bocchino, L
    Takeshita, N
    Bhayana, JN
    Bergsland, J
    Graham, S
    Houck, JP
    Salerno, TA
    ANNALS OF THORACIC SURGERY, 1997, 64 (03): : 634 - 638
  • [32] Left ventricular volume reduction for end-stage heart disease
    Vanelli, P
    Beretta, L
    Fundarò, PM
    Carro, C
    Santoli, C
    Mangini, A
    Condemi, AR
    Castelli, P
    Munari, M
    JOURNAL OF CARDIAC SURGERY, 1999, 14 (01) : 60 - 63
  • [33] Clinical outcomes of patients with end-stage heart failure treated with left ventricular assist devices
    Di Carlo, Marta
    Marchetti, Maria Francesca
    Tramontin, Corrado
    Corda, Marco
    Porcu, Maurizio
    Agus, Elena
    Boi, Giacomo
    Cirio, Emiliano
    Meloni, Luigi
    Montisci, Roberta
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (SUPPL G)
  • [34] Relationship between QRS duration and left ventricular dyssynchrony in patients with end-stage heart failure
    Bleeker, GB
    Schalij, MJ
    Molhoek, SG
    Verwey, HF
    Holman, ER
    Boersma, E
    Steendijk, P
    Van Der Wall, EE
    Bax, JJ
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2004, 15 (05) : 544 - 549
  • [35] Sex Differences in Patients Receiving Left Ventricular Assist Devices for End-Stage Heart Failure
    Gruen, Jadry
    Caraballo, Cesar
    Miller, P. Elliott
    McCullough, Megan
    Mezzacappa, Catherine
    Ravindra, Neal
    Mullan, Clancy W.
    Reinhardt, Samuel W.
    Mori, Makoto
    Velazquez, Eric
    Geirsson, Arnar
    Ahmad, Tariq
    Desai, Nihar R.
    JACC-HEART FAILURE, 2020, 8 (09) : 770 - 779
  • [36] LEFT VENTRICULAR ASSIST DEVICE DOES NOT IMPROVE CELLULAR IMMUNITY IN END-STAGE HEART FAILURE
    Lundgren, Scott
    Lyden, Elizabeth
    Burdorf, Adam
    Hyden, Marshall
    Stoller, Douglas
    Zolty, Ronald
    Um, John
    Lowes, Brian
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 950 - 950
  • [37] Left ventricular volume reduction for end-stage heart failure: New horizon or false dawn?
    Bryan, AJ
    Angelini, GD
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 1997, 57 (07): : 323 - 325
  • [38] Preliminary experience with the LionHeart left ventricular assist device in patients with end-stage heart failure
    El-Banayosy, A
    Arusoglu, L
    Kizner, L
    Morshuis, M
    Tenderich, G
    Pae, WE
    Körfer, R
    ANNALS OF THORACIC SURGERY, 2003, 75 (05): : 1469 - 1475
  • [39] Mechanical Dyssynchrony of Isolated Left and Right Ventricular Human Myocardium in End-Stage Heart Failure
    Mashali, Mohammed A.
    Saad, Nancy S.
    Peczkowski, Kyra K.
    Fanning, Tom
    Hare, Austin N.
    Whitson, Bryan A.
    Mokadam, Nahush A.
    Janssen, Paul M. L.
    CIRCULATION-HEART FAILURE, 2023, 16 (03) : 289 - 303
  • [40] Left Ventricular Assist Devices for destination therapy in end-stage heart failure: The REMATCH trial
    Farrar, DJ
    SECOND JOINT EMBS-BMES CONFERENCE 2002, VOLS 1-3, CONFERENCE PROCEEDINGS: BIOENGINEERING - INTEGRATIVE METHODOLOGIES, NEW TECHNOLOGIES, 2002, : 1556 - 1557